Swallow this pill: new capsule could spot internal bleeding instantly
NCT ID NCT06715293
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a wireless capsule called Hemopill that patients swallow to detect active bleeding in the upper digestive tract. Researchers will compare its accuracy to standard endoscopy in 193 people with signs of bleeding. If it works, the capsule could help doctors quickly decide who needs emergency treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Hemopill (wireless optical sensor capsule)
What this could lead to
If successful, this capsule could provide a fast, non-invasive way to detect upper GI bleeding, helping doctors decide who needs urgent endoscopy and who can wait.
What could go wrong
This is an early-stage study with only 193 participants. The capsule may not detect all bleeding types, and results need confirmation in larger, more diverse groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL BLEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Prince of Wales Hospital
RECRUITINGShatin, Hong Kong Island, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••